ENTPD2 upregulation is demonstrated in papillary thyroid carcinoma‐derived cells, esophageal cancer cells, gliomas cells, and liver cancer cells in contrast to normal cells.80, 81, 82, 83. Here, ENTPD2 is linked to thyroid gland papillary carcinoma.